Kolexia
Callet Bauchu Evelyne
Biologie médicale
Université de Lyon
Villeurbanne, France
66 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Aberrations des chromosomes Lymphome B de la zone marginale Leucémie chronique lymphocytaire à cellules B Leucémies Lymphome B Leucémie lymphoïde Tumeurs spléniques Lymphome à cellules du manteau

Industries

Gilead
2 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Variability in CD39 and CD73 protein levels in uveal melanoma patients.
Nucleosides, nucleotides & nucleic acids   24 février 2022
Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases
Blood   23 novembre 2021
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Blood   28 février 2020
Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
Annals of hematology   20 novembre 2019
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Annals of hematology   19 novembre 2019
Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort.
Cancers   04 octobre 2019
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.
Haematologica   13 décembre 2018
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group
Blood   29 novembre 2018
Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2TM and RESONATETM with RW Databases
Blood   29 novembre 2018
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.
Oncotarget   04 mai 2018